These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1690651)

  • 1. Preparation of monoclonal antibodies to hirudin and hirudin peptides. A method for studying the hirudin--thrombin interaction.
    Schlaeppi JM; Vekemans S; Rink H; Chang JY
    Eur J Biochem; 1990 Mar; 188(2):463-70. PubMed ID: 1690651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of monoclonal antibodies to the thrombin/hirudin complex.
    Schlaeppi JM
    Thromb Res; 1991 Jun; 62(5):459-70. PubMed ID: 1896964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids.
    Koch C; Whitechurch O; Cordier P; Roitsch C
    Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.
    Bode C; Hudelmayer M; Mehwald P; Bauer S; Freitag M; von Hodenberg E; Newell JB; Kübler W; Haber E; Runge MS
    Circulation; 1994 Oct; 90(4):1956-63. PubMed ID: 7923685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin activity of the hirudin N-terminal core domain residues 1-43.
    Chang JY; Schlaeppi JM; Stone SR
    FEBS Lett; 1990 Jan; 260(2):209-12. PubMed ID: 2404798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the structure of hirudin from Hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments.
    Vindigni A; De Filippis V; Zanotti G; Visco C; Orsini G; Fontana A
    Eur J Biochem; 1994 Dec; 226(2):323-33. PubMed ID: 8001550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY
    J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity.
    Mao SJ; Yates MT; Owen TJ; Krstenansky JL
    Biochemistry; 1988 Oct; 27(21):8170-3. PubMed ID: 3233202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hirudin C-terminal fragments inhibit thrombin induced neutrophil chemotaxis.
    Rowand JK; Marucha P; Berliner LJ
    Thromb Haemost; 1992 Mar; 67(3):289-91. PubMed ID: 1641817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of site specific amino acid exchanges in hirudin on the thrombin-hirudin interaction.
    Köhler S; Dodt J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):24-9. PubMed ID: 2459027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-site immunoassay of recombinant hirudin based on two monoclonal antibodies.
    Mille B; Condamines O; Herbert JM; Maftouh M; Picard C; Dussossoy D; Pau B
    Clin Chem; 1994 May; 40(5):734-9. PubMed ID: 7513626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL; Mao SJ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced effect of inhibition of thrombin on endothelium in murine endotoxaemia: specific inhibition of thrombocytopenia.
    Chen D; McVey JH; Dorling A
    Thromb Res; 2013; 132(6):750-6. PubMed ID: 24161661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner.
    Peter K; Gupta A; Nordt T; Bauer S; Runge MS; Bode C
    J Cardiovasc Pharmacol; 2003 Aug; 42(2):237-44. PubMed ID: 12883328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for the detection of active-site specific thrombin inhibitors in biological fluids. I. Assay characteristics and quantitation of recombinant hirudin.
    Lackmann M; Hoad R; Kakakios A; Geczy CL
    Thromb Res; 1991 Sep; 63(6):595-607. PubMed ID: 1780804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of thrombin in immunological assays for hirudin specific antibodies.
    Hamilton RG; Levy JH; Marder VJ; Sane DC
    J Immunol Methods; 2012 Jul; 381(1-2):50-8. PubMed ID: 22542931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM; Hoppensteadt D; Koza M; Wallock M; Pifarre R; Fareed J
    Haemostasis; 1991; 21 Suppl 1():49-63. PubMed ID: 1894197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.